Tumor-Directed Oncolytic Therapies for Melanoma and CSCC
Source: OncLive, May 2023
Sunandana Chandra, MD, MS: Let’s switch gears and talk about the treatment modality of tumor-directed oncolytic therapies. These are intralesional therapies that many medical oncologists often employ in our practices. Dr Khushalani, when do you consider usage of this particular treatment modality for your patients?
Nikhil Khushalani, MD: Specifically for squamous cell, melanoma, or both?
Sunandana Chandra, MD, MS: For either.